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Origins of mitotic inequality
A
ll cells are not equal, at least when it comes to the length of the cell 
cycle. Asymmetric distribution of two regulatory proteins in the early 
embryo helps create these timing differences, Rivers et al. show.
Different cell types often differ in cell cycle length. Take AB and P1, the 
ﬁ  rst two cells of a worm embryo. AB completes its cycle about two minutes 
sooner than does P1. Researchers knew that Par proteins, which help set up 
the embryo’s polarity, are also responsible for unequal cell cycle times. What 
they didn’t know was how.
Rivers et al. tested whether two key proteins that control the cell cycle, 
cyclin E and CDC-25.1, were involved. AB and P1 harbored equal amounts 
of cyclin E, indicating it wasn’t responsible for the timing difference. But the 
levels of CDC-25.1 are higher in the AB cell’s nucleus, and the protein builds 
up faster there, suggesting it drives the asynchrony.
But what causes CDC-25.1 to accumulate in only one cell? One candidate 
was the polo-like kinase PLK-1, which helps the human counterpart of CDC-25.1 
home in on the nucleus. Rivers et al. found that at the one-celled stage, PLK-1 
amasses at the anterior end, which becomes AB after the ﬁ  rst cell division.
In turn, Par proteins seem to help set up the PLK-1 asymmetry through 
two other proteins, which control protein degradation. These two proteins 
might spur the breakdown of an unidentiﬁ  ed inhibitor of PLK-1. 
Rivers, D.M., et al. 2008. J. Cell Biol. 180:877–885.
Cells’ puncture 
repair kit
A 
cell with a torn or perforated mem-
brane has to close the breach fast. To 
heal wounds inﬂ   icted by bacteria, 
cells rely on endocytosis, Idone et al. show.
An injury or even a workout at the gym 
can tear the plasma membranes of our cells. 
Earlier work showed that a wounded cell 
makes repairs through exocytosis, extruding 
lysosomes whose membranes help close the 
rip. But this mechanism alone can’t explain 
how cells heal all injuries. Some bacterial 
toxins and defensive proteins such as the 
complement system embed themselves in 
the membrane, forming a pore that can’t be 
closed by exocytosis. Idone et al. wanted to 
nail down how cells mend these types of 
perforations.
The team exposed cells to Streptococcus 
toxin that bores into the plasma membrane. 
Repairs were quick—the membranes resealed 
in less than 30 seconds. Cells wouldn’t have 
time to disassemble the pores in that time, 
ruling out one possible mechanism. The team 
also discounted the possibility that injury-
induced blebs on the cell membrane some-
how dislodge the pores—cells still healed 
when the team blocked blebbing.
A third possibility is that cells use en-
docytosis to remove the pores from the 
membrane. To test the idea, Idone et al. fol-
lowed labeled pores that were stuck in the 
membrane. Within a few seconds, endo-
somes carrying tagged toxin began show-
ing up inside the cells. The results indicate 
that injury stimulates the formation of endo-
somes that engulf pores that have penetrated 
the membrane. The team also discovered 
that cells use the same method to excise 
membrane abrasions. 
Idone, C., et al. 2008. J. Cell Biol. 
180:905–914.
SIRT2 stops cells
R
ecent work from Pandithage et al. reveals a new pathway for controlling 
cell movement that involves a cancer enabler and a member of a 
protein family best known for boosting longevity.
The researchers chanced on the discovery while investigating the oncogene 
Myc, which is overactive in many tumors. Myc activates cyclin E and cyclin-
dependent kinase (CDK)—a protein power couple that pushes cells through the 
cell cycle. The team wanted to determine what lies downstream of this pair.
One of the pair’s targets, they found, is SIRT2, a member of the sirtuin 
protein family. Sirtuins take part in everything from insulin secretion to tran-
scription and can extend life span in organisms such as nematodes and yeast. 
The cyclin E/CDK pair and other cyclin/CDK combinations phosphorylate 
SIRT2 to shut it down, the team found.
SIRT2 cleaves acetyl groups off histones and α-tubulin. As a result of its 
tubulin effects, SIRT2 destabilizes microtubules. The group found that by 
preventing microtubule extension, SIRT2 stopped tumor cells from getting a 
good grip on the substrate—a necessity for crawling. Thus by indirectly shutting 
off SIRT2, Myc might prompt the migration of cancer cells.
SIRT2 also blocked the protrusion of neurites from brain neurons. The work 
indicates that this enzyme helps maintain the status quo in cells by regulating 
microtubule stability. Recent studies implicate SIRT2 in neurodegeneration, 
which suggests that this pathway could also be involved in illnesses such as 
Parkinson’s disease. 
Pandithage, R., et al. 2008. J. Cell Biol. 180:915–929.
CDC-25.1 (green) is asymmetrically distributed at the two-cell stage (left and center) 
but not at the ﬁ  rst telophase (right).
Endosomes contain either removed bacterial toxins 
(left) or damaged membrane (right).